On May 9, 2019 the Food and Drug Administration issued a “Recommendations for Reducing the Risk of Transfusion-Transmitted Babesiosis” guidance document with a maximum 12 month implementation timeline. Per the FDA guidance document recommendations, CTS is developing a specific implementation plan for mandatory Babesia testing well before the May 8, 2020 deadline.
Check out the Communication page for the complete details by clicking the link: Communications
As a friendly reminder, airlines often change their routine flights and cargo hours for hol...
On Wednesday August 15, 2018 at 11:00AM PDT, we will be hosting a webinar regarding the changes to F...
Reminder - Dr. Buff Mair is the new CTS Medical Director. Several of the CTS client forms specify li...
In 2016, the Procleix Panther instrument was introduced by Grifols in support of automated NAT ZIKA ...
National Blood Donor Month has been observed in January since 1970, with the goal of increasing bloo...
The revised CTS algorithm associated with the Ortho platform is now available for review. Clie...